| Lung Cancer Surgery: Decisions Against Life Saving Care - The Intervention (NCT01687738) | University of North Carolina, Chapel Hill | 2012-08-01 |
| Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT) (NCT01511081) | M.D. Anderson Cancer Center | 2012-08-01 |
| Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer (NCT01688713) | Zhejiang Cancer Hospital | 2012-08-01 |
| A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC] (NCT01714037) | Debiopharm International SA | 2012-08-01 |
| Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma (NCT01574729) | Shenzhen SiBiono GeneTech Co.,Ltd | 2012-08-01 |
| Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer (NCT01666977) | Amgen | 2012-08-01 |
| A Study of LY3023414 in Participants With Advanced Cancer (NCT01655225) | Eli Lilly and Company | 2012-07-31 |
| Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot Project (NCT02459002) | M.D. Anderson Cancer Center | 2012-07-18 |
| First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients (NCT01646450) | Betta Pharmaceuticals Co., Ltd. | 2012-07-01 |
| Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity (NCT01639508) | Memorial Sloan Kettering Cancer Center | 2012-07-01 |
| Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease (NCT01784549) | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 2012-07-01 |
| MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases (NCT01640847) | Imunon | 2012-07-01 |
| A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin (NCT01641575) | Clovis Oncology, Inc. | 2012-07-01 |
| BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology (NCT01660776) | Rennes University Hospital | 2012-06-07 |
| Enumeration of Circulating Tumour Cells (CTCs) in Patients With Advanced Solid Malignancy Using Complementary Metal Oxide Semiconductor (CMOS) Technology (NCT01596452) | National University Hospital, Singapore | 2012-06-01 |
| Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer (NCT01625234) | Xcovery Holdings, Inc. | 2012-06-01 |
| Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer (NCT01619241) | The Catholic University of Korea | 2012-06-01 |
| Role of SPECT in Radiotherapy of Lung Cancer and Toxicity Evaluation (NCT01745484) | University of Aarhus | 2012-06-01 |
| Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung Cancer (NCT01605916) | AstraZeneca | 2012-06-01 |
| Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer From Fine Needle Aspirates (NCT01630122) | Wake Forest University Health Sciences | 2012-06-01 |
| Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation Therapy (NCT01808677) | M.D. Anderson Cancer Center | 2012-06-01 |
| Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan) (NCT01597258) | Pfizer | 2012-05-29 |
| Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer (NCT02720614) | LIN QIANG | 2012-05-01 |
| A Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47 (NCT02340208) | Helix BioPharma Corporation | 2012-05-01 |
| Perioperative Rehabilitation in Operation for Lung Cancer (NCT01893580) | Rigshospitalet, Denmark | 2012-05-01 |
| Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations. (NCT01525199) | AstraZeneca | 2012-05-01 |
| Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer (NCT01545947) | Celgene | 2012-05-01 |
| ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer (NCT01580735) | Kyowa Kirin Co., Ltd. | 2012-05-01 |
| EGF Ointment for Erlotinib Skin Lesion (NCT01593995) | Dong-A University Hospital | 2012-05-01 |
| A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment (NCT01610336) | Novartis Pharmaceuticals | 2012-04-05 |
| Irinotecan for Previously Treated, Advanced, Non-Small Cell Lung Cancer (NCT01607554) | New Mexico Cancer Research Alliance | 2012-04-01 |
| Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer (NCT01617980) | German Cancer Research Center | 2012-04-01 |
| A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer (NCT02364804) | Shiga University | 2012-04-01 |
| First Line Gefitinib by FDG-PET Metabolic Response (NCT01510990) | Asan Medical Center | 2012-04-01 |
| A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC) (NCT01562015) | Synta Pharmaceuticals Corp. | 2012-04-01 |
| A Study of IRESSA Treatment Beyond Progression in Addition to Chemotherapy Versus Chemotherapy Alone (NCT01544179) | AstraZeneca | 2012-03-15 |
| Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer (NCT01593293) | Asan Medical Center | 2012-03-01 |
| GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial (NCT02319577) | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 2012-03-01 |
| An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite) (NCT01598597) | Genentech, Inc. | 2012-03-01 |
| A Study of Prevalence of EGFR Mutations in Participants With NSCLC (NCT02695849) | Hoffmann-La Roche | 2012-03-01 |
| Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer (NCT01565772) | Massachusetts General Hospital | 2012-03-01 |
| Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients (NCT01588145) | Hanmi Pharmaceutical Company Limited | 2012-03-01 |
| Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers (NCT01502202) | National Cancer Center, Korea | 2012-03-01 |
| A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NCT01560104) | AbbVie (prior sponsor, Abbott) | 2012-02-01 |
| Integrated Molecular Profiling in Advanced Cancers Trial (NCT01505400) | University Health Network, Toronto | 2012-02-01 |
| A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT01667562) | Hoffmann-La Roche | 2012-01-20 |
| Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer (NCT01493843) | Genentech, Inc. | 2012-01-20 |
| A Phase I Trial of Vandetanib (AZD6474) and Selumetinib (AZD6244) for Solid Tumours Including Non Small Cell Lung Cancer (VanSel-1) (NCT01586624) | Cancer Research UK | 2012-01-10 |
| Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC) (NCT01951755) | University of Athens | 2012-01-01 |
| Genotyping of Non-small Cell Lung Cancer (NCT02002117) | National Taiwan University Hospital | 2012-01-01 |
| Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer (NCT01542437) | Instituto Nacional de Cancerologia de Mexico | 2012-01-01 |
| Common Safety Follow-up Trial of Tecemotide (L-BLP25) (NCT01423760) | Merck KGaA, Darmstadt, Germany | 2012-01-01 |
| Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment (NCT01520389) | Merrimack Pharmaceuticals | 2012-01-01 |
| A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors (NCT01457417) | Leap Therapeutics, Inc. | 2012-01-01 |
| RT Plus EGFR-TKI for Wild-type NSCLC (NCT02738983) | Hangzhou Cancer Hospital | 2012-01-01 |
| Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing Treatment (NCT02895503) | Virginia Commonwealth University | 2012-01-01 |
| Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC) (NCT01837186) | University Hospital, Gasthuisberg | 2012-01-01 |
| Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC (NCT01963351) | University of Athens | 2012-01-01 |
| Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients (NCT01402089) | Markus Joerger | 2012-01-01 |
| Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II (NCT01649947) | Rutgers, The State University of New Jersey | 2011-12-23 |
| Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012) (NCT01454102) | Bristol-Myers Squibb | 2011-12-16 |
| Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer (NCT01407822) | Guangdong Association of Clinical Trials | 2011-12-05 |
| ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLC (NCT01810367) | Fudan University | 2011-12-01 |
| Immune Response and Safety of HS110 Vaccine in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer (NCT01504542) | Heat Biologics | 2011-12-01 |
| Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC (NCT01528488) | Sun Yat-sen University | 2011-12-01 |
| Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation (NCT01516983) | Betta Pharmaceuticals Co., Ltd. | 2011-12-01 |
| Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung (NCT01561456) | Axelar AB | 2011-12-01 |
| Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging (NCT01473693) | Memorial Sloan Kettering Cancer Center | 2011-11-01 |
| Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients (NCT01441752) | xuling | 2011-11-01 |
| Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy (NCT01482182) | Samsung Medical Center | 2011-11-01 |
| A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments (NCT01529112) | Eisai Inc. | 2011-11-01 |
| Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer (NCT01532362) | Jonsson Comprehensive Cancer Center | 2011-11-01 |
| A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR (NCT01570296) | National Cancer Centre, Singapore | 2011-10-03 |
| A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers (NCT01451632) | Merrimack Pharmaceuticals | 2011-10-01 |
| Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease (NCT01450553) | Precision Therapeutics | 2011-10-01 |
| A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy (NCT01351116) | Ontario Clinical Oncology Group (OCOG) | 2011-10-01 |
| A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations (NCT01287754) | Hoffmann-La Roche | 2011-10-01 |
| Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation (NCT01405079) | Guangdong Association of Clinical Trials | 2011-09-19 |
| Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose (NCT01465243) | Betta Pharmaceuticals Co., Ltd. | 2011-09-01 |
| Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy (NCT01664663) | Ass. Prof. Jan Nyman | 2011-09-01 |
| Proton Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer (NCT01525446) | Massachusetts General Hospital | 2011-09-01 |
| Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung Cancer (NCT01950156) | Shiga University | 2011-09-01 |
| Study of Use of CTC in NSCLC (NCT01990651) | University of Virginia | 2011-09-01 |
| A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers (NCT01521325) | Morphotek | 2011-09-01 |
| Establishment and Characterization of Patient-Derived Non-Small Cell Lung Cancer Xenografts and Cell Cultures (NCT01130571) | National University Hospital, Singapore | 2011-09-01 |
| A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients (NCT01531790) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2011-09-01 |
| Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC) (NCT01549093) | Hunan Province Tumor Hospital | 2011-08-01 |
| CIK Cell Transfusion Plus Chemotherapy as Adjuvant Therapy for Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) (NCT01533727) | Sun Yat-sen University | 2011-08-01 |
| Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer (NCT01949701) | Shiga University | 2011-08-01 |
| Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone (NCT01513174) | Spanish Lung Cancer Group | 2011-08-01 |
| A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study of ARQ 197 Plus Erlotinib Versus Placebo Plus Erlotinib (NCT01377376) | Kyowa Kirin Co., Ltd. | 2011-07-01 |
| Gilotrif (Afatinib) in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib (NCT02747953) | Samsung Medical Center | 2011-07-01 |
| Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer (NCT01427946) | Infinity Pharmaceuticals, Inc. | 2011-07-01 |
| Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2) (NCT01387282) | Helsinn Therapeutics (U.S.), Inc | 2011-07-01 |
| Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum (NCT01355497) | GTx | 2011-07-01 |
| Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) (NCT01355484) | GTx | 2011-07-01 |
| Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase Expression (NCT01401192) | Samsung Medical Center | 2011-07-01 |
| Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1) (NCT01387269) | Helsinn Therapeutics (U.S.), Inc | 2011-07-01 |
| Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC) (NCT01391260) | ZhuGuangYing | 2011-07-01 |
| Safety Study of MGA271 in Refractory Cancer (NCT01391143) | MacroGenics | 2011-07-01 |